Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis

A systematic review

Simona Ferrarow, Federica Braga, Monica Lanzoni, Patrizia Boracchi, Elia Mario Biganzoli, Mauro Panteghini

Research output: Contribution to journalArticle

95 Citations (Scopus)

Abstract

Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving the specificity of laboratory identification of ovarian cancer (OC). Objective To critically revise the available literature on the comparison between the diagnostic accuracy of HE4 and carbohydrate antigen 125 (CA-125) to confirm the additional clinical value of HE4. Methods A literature search was undertaken on electronic databases and references from retrieved articles; articles were analysed according to predefined criteria. Meta-analyses for HE4 and CA-125 biomarkers with OR, diagnostic sensitivity, specificity, positive (LR+) and negative (LR-) likelihood ratios as effect sizes were performed. Results 16 articles were originally included in metaanalyses, but two for HE4 and one for CA-125 were eliminated as outliers. Furthermore, for HE4 a publication bias was detected. ORs for both HE4 (37.2, 95% CI 19.0 to 72.7, adjusted for publication bias) and CA-125 (15.4, 95% CI 10.4 to 22.8) were significant, although in a heterogeneous set of studies (p

Original languageEnglish
Pages (from-to)273-281
Number of pages9
JournalJournal of Clinical Pathology
Volume66
Issue number4
DOIs
Publication statusPublished - Apr 2013

Fingerprint

Epididymis
Ovarian Neoplasms
Carbohydrates
Antigens
Serum
Proteins
Publication Bias
Meta-Analysis
Biomarkers
Databases
Sensitivity and Specificity

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis : A systematic review. / Ferrarow, Simona; Braga, Federica; Lanzoni, Monica; Boracchi, Patrizia; Biganzoli, Elia Mario; Panteghini, Mauro.

In: Journal of Clinical Pathology, Vol. 66, No. 4, 04.2013, p. 273-281.

Research output: Contribution to journalArticle

Ferrarow, Simona ; Braga, Federica ; Lanzoni, Monica ; Boracchi, Patrizia ; Biganzoli, Elia Mario ; Panteghini, Mauro. / Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis : A systematic review. In: Journal of Clinical Pathology. 2013 ; Vol. 66, No. 4. pp. 273-281.
@article{2c75556eb5574e679b59a8648929d5ae,
title = "Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis: A systematic review",
abstract = "Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving the specificity of laboratory identification of ovarian cancer (OC). Objective To critically revise the available literature on the comparison between the diagnostic accuracy of HE4 and carbohydrate antigen 125 (CA-125) to confirm the additional clinical value of HE4. Methods A literature search was undertaken on electronic databases and references from retrieved articles; articles were analysed according to predefined criteria. Meta-analyses for HE4 and CA-125 biomarkers with OR, diagnostic sensitivity, specificity, positive (LR+) and negative (LR-) likelihood ratios as effect sizes were performed. Results 16 articles were originally included in metaanalyses, but two for HE4 and one for CA-125 were eliminated as outliers. Furthermore, for HE4 a publication bias was detected. ORs for both HE4 (37.2, 95{\%} CI 19.0 to 72.7, adjusted for publication bias) and CA-125 (15.4, 95{\%} CI 10.4 to 22.8) were significant, although in a heterogeneous set of studies (p",
author = "Simona Ferrarow and Federica Braga and Monica Lanzoni and Patrizia Boracchi and Biganzoli, {Elia Mario} and Mauro Panteghini",
year = "2013",
month = "4",
doi = "10.1136/jclinpath-2012-201031",
language = "English",
volume = "66",
pages = "273--281",
journal = "Journal of Clinical Pathology - Clinical Molecular Pathology",
issn = "0021-9746",
publisher = "BMJ Publishing Group",
number = "4",

}

TY - JOUR

T1 - Serum human epididymis protein 4 vs carbohydrate antigen 125 for ovarian cancer diagnosis

T2 - A systematic review

AU - Ferrarow, Simona

AU - Braga, Federica

AU - Lanzoni, Monica

AU - Boracchi, Patrizia

AU - Biganzoli, Elia Mario

AU - Panteghini, Mauro

PY - 2013/4

Y1 - 2013/4

N2 - Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving the specificity of laboratory identification of ovarian cancer (OC). Objective To critically revise the available literature on the comparison between the diagnostic accuracy of HE4 and carbohydrate antigen 125 (CA-125) to confirm the additional clinical value of HE4. Methods A literature search was undertaken on electronic databases and references from retrieved articles; articles were analysed according to predefined criteria. Meta-analyses for HE4 and CA-125 biomarkers with OR, diagnostic sensitivity, specificity, positive (LR+) and negative (LR-) likelihood ratios as effect sizes were performed. Results 16 articles were originally included in metaanalyses, but two for HE4 and one for CA-125 were eliminated as outliers. Furthermore, for HE4 a publication bias was detected. ORs for both HE4 (37.2, 95% CI 19.0 to 72.7, adjusted for publication bias) and CA-125 (15.4, 95% CI 10.4 to 22.8) were significant, although in a heterogeneous set of studies (p

AB - Background Human epididymis protein 4 (HE4) measurements in serum have been proposed for improving the specificity of laboratory identification of ovarian cancer (OC). Objective To critically revise the available literature on the comparison between the diagnostic accuracy of HE4 and carbohydrate antigen 125 (CA-125) to confirm the additional clinical value of HE4. Methods A literature search was undertaken on electronic databases and references from retrieved articles; articles were analysed according to predefined criteria. Meta-analyses for HE4 and CA-125 biomarkers with OR, diagnostic sensitivity, specificity, positive (LR+) and negative (LR-) likelihood ratios as effect sizes were performed. Results 16 articles were originally included in metaanalyses, but two for HE4 and one for CA-125 were eliminated as outliers. Furthermore, for HE4 a publication bias was detected. ORs for both HE4 (37.2, 95% CI 19.0 to 72.7, adjusted for publication bias) and CA-125 (15.4, 95% CI 10.4 to 22.8) were significant, although in a heterogeneous set of studies (p

UR - http://www.scopus.com/inward/record.url?scp=84875224028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875224028&partnerID=8YFLogxK

U2 - 10.1136/jclinpath-2012-201031

DO - 10.1136/jclinpath-2012-201031

M3 - Article

VL - 66

SP - 273

EP - 281

JO - Journal of Clinical Pathology - Clinical Molecular Pathology

JF - Journal of Clinical Pathology - Clinical Molecular Pathology

SN - 0021-9746

IS - 4

ER -